![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel | Konferenzbeitrag
Anzahl der Publikationen: 22
Zeitschriftenartikel
Fischer, Luca 
ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Schmidt, Christian; Stilgenbauer, Stephan ORCID: https://orcid.org/0000-0002-6830-9296; Bouabdallah, Krimo; Solal-Celigny, Philippe; Scholz, Christian W.; Feugier, Pierre; Wit, Maike de; Trappe, Ralf Ulrich; Hallek, Michael; Graeven, Ullrich ORCID: https://orcid.org/0000-0001-6082-7710; Hänel, Mathias; Hoffmann, Martin; Delwail, Vincent; Macro, Margaret; Greiner, Jochen ORCID: https://orcid.org/0000-0003-1256-173X; Giagounidis, Aristoteles A. N.; Dargel, Beate; Durot, Eric ORCID: https://orcid.org/0000-0003-3463-0089; Foussard, Charles; Silkenstedt, Elisabeth; Weigert, Oliver ORCID: https://orcid.org/0000-0002-0987-7373; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Ribrag, Vincent und Dreyling, Martin
(2024):
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network.
In: Leukemia, Bd. 38: S. 1307-1314
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Schmidt, Christian; Stilgenbauer, Stephan ORCID: https://orcid.org/0000-0002-6830-9296; Bouabdallah, Krimo; Solal-Celigny, Philippe; Scholz, Christian W.; Feugier, Pierre; Wit, Maike de; Trappe, Ralf Ulrich; Hallek, Michael; Graeven, Ullrich ORCID: https://orcid.org/0000-0001-6082-7710; Hänel, Mathias; Hoffmann, Martin; Delwail, Vincent; Macro, Margaret; Greiner, Jochen ORCID: https://orcid.org/0000-0003-1256-173X; Giagounidis, Aristoteles A. N.; Dargel, Beate; Durot, Eric ORCID: https://orcid.org/0000-0003-3463-0089; Foussard, Charles; Silkenstedt, Elisabeth; Weigert, Oliver ORCID: https://orcid.org/0000-0002-0987-7373; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Ribrag, Vincent und Dreyling, Martin
(2024):
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network.
In: Leukemia, Bd. 38: S. 1307-1314
[PDF, 1MB]
Jacob, Anne Sophie; Kaul, Helen; Fuchs, Michael; Gillessen, Sarah; Kreissl, Stefanie; Pluetschow, Annette; Momotow, Jesko; Schaub, Valdete; Huettmann, Andreas; Haenel, Mathias; Zimmermann, Andreas; Dierlamm, Judith; Meissner, Julia; Mathas, Stephan; Martin, Sonja; Engert, Andreas; Hallek, Michael; Borchmann, Peter und Lehmann, Clara
(2022):
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
In: Infection, Bd. 50, Nr. 4: S. 925-932
Arndt, Volker; Doege, Daniela; Froehling, Stefan; Albers, Peter; Alguel, Hana; Bargou, Ralf; Bokemeyer, Carsten; Bornhaeuser, Martin; Brandts, Christian H.; Brossart, Peter; Brucker, Sara Yvonne; Bruemmendorf, Tim H.; Doehner, Hartmut; Gattermann, Norbert; Hallek, Michael; Heinemann, Volker; Keilholz, Ulrich; Kindler, Thomas; Levetzow, Cornelia von; Lordick, Florian; Neumann, Ulf Peter; Peters, Christoph; Schadendorf, Dirk; Stilgenbauer, Stephan; Zander, Thomas; Zips, Daniel; Braun, Delia; Seufferlein, Thomas; Nettekoven, Gerd und Baumann, Michael
(2022):
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 2: S. 913-919
Stilgenbauer, Stephan; Morschhauser, Franck; Wendtner, Clemens-Martin; Cartron, Guillaume; Hallek, Michael; Eichhorst, Barbara; Kozloff, Mark F.; Giever, Thomas; Lozanski, Gerard; Jiang, Yanwen; Huang, Huang; Pignataro, Daniela Soriano; Schary, William; Humphrey, Kathryn; Mobasher, Mehrdad und Salles, Gilles
(2021):
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440).
In: Haematologica, Bd. 106, Nr. 11: S. 2834-2844
Borchmann, Peter; Plutschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S.; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sokler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V.; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Huttmann, Andreas; Wilhelm, Martin; Zijlstra, Josee M.; Moccia, Alden; Kuhnert, Georg; Brockelmann, Paul J.; Tresckow, Bastian von; Fuchs, Michael; Klimm, Beate; Rosenwald, Andreas; Eich, Hans; Baues, Christian; Marnitz, Simone; Hallek, Michael; Diehl, Volker; Dietlein, Markus und Engert, Andreas
(2021):
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 22, Nr. 2: S. 223-234
Rothe, Achim; Classen, Annika; Carney, Jonathan; Hallek, Michael; Mellinghoff, Sibylle C.; Scheid, Christoph; Holtick, Udo und Bergwelt-Baildon, Michael von
(2020):
Bridging antifungal prophylaxis with 50 mg or 100 mg micafungin in allogeneic stem cell transplantation: A retrospective analysis.
In: European Journal of Haematology, Bd. 104, Nr. 4: S. 291-298
Knuever, Jana; Weiss, Jonathan; Persa, Oana-Diana; Kreuzer, Karl; Mauch, Cornelia; Hallek, Michael und Schlaak, Max
(2020):
The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients.
In: Scientific Reports, Bd. 10, Nr. 1, 4940
[PDF, 1MB]
Schuldner, Maximiliane; Doersam, Bastian; Shatnyeva, Olga; Reiners, Katrin S.; Kubarenko, Andriy; Hansen, Hinrich P.; Finkernagel, Florian; Roth, Katrin; Theurich, Sebastian; Nist, Andrea; Stiewe, Thorsten; Paschen, Annette; Knittel, Gero; Reinhardt, Hans C.; Müller, Rolf; Hallek, Michael und Strandmann, Elke Pogge von
(2019):
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53.
In: Theranostics, Bd. 9, Nr. 21: S. 6047-6062
Jebaraj, Billy Michael Chelliah; Tausch, Eugen; Landau, Dan A.; Bahlo, Jasmin; Robrecht, Sandra; Taylor-Weiner, Amaro N.; Bloehdorn, Johannes; Scheffold, Annika; Mertens, Daniel; Böttcher, Sebastian; Kneba, Michael; Jaeger, Ulrich; Zenz, Thorsten; Wenger, Michael K.; Fingerle-Rowson, Guenter; Wendtner, Clemens; Fink, Anna-Maria; Wu, Catherine J.; Eichhorst, Barbara; Fischer, Kirsten; Hallek, Michael; Doehner, Hartmut und Stilgenbauer, Stephan
(2019):
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia.
In: Leukemia, Bd. 33, Nr. 9: S. 2183-2194
Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Duerig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco und Hopfinger, Georg
(2019):
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.
In: Leukemia & Lymphoma, Bd. 60, Nr. 3: S. 649-657
Rice, Carmel; Eikema, Dirk-Jan; Marsh, Judith C. W.; Knol, Cora; Hebert, Kyle; Putter, Hein; Peterson, Eefke; Deeg, H. Joachim; Halkes, Stijn; Pidala, Joseph; Anderlini, Paolo; Tischer, Johanna; Kroger, Nicolaus; McDonald, Andrew; Antin, Joseph H.; Schaap, Nicolaas P.; Hallek, Michael; Einsele, Herman; Mathews, Vikram; Kapoor, Neena; Boelens, Jaap-Jan; Mufti, Ghulam J.; Potter, Victoria; de la Tour, Regis Pefault; Eapen, Mary und Dufour, Carlo
(2019):
Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50 Years or Older with Severe Aplastic Anemia.
In: Biology of Blood and Marrow Transplantation, Bd. 25, Nr. 3: S. 488-495
Gartner, Jan; Daun, Marion; Wolf, Jürgen; Bergwelt-Baildon, Michael von und Hallek, Michael
(2019):
Early Palliative Care: Pro, but Please Be Precise!
In: Oncology Research and Treatment, Bd. 42, Nr. 1-2: S. 11-18
Gorkom, Gwendolyn van; Gelder, Michel van; Eikema, Dirk-Jan; Blok, Henric-Jan; Lint, M. T. van; Koc, Yener; Ciceri, Fabio; Beelen, Dietrich; Chevallier, Patrice; Selleslag, Dominik; Blaise, Didier; Foa, Roberto; Corradini, Paolo; Castagna, Luca; Moreno, Carol; Solano, Carlos; Müller, Lutz Peter; Tischer, Johanna; Hilgendorf, Inken; Hallek, Michael; Bittenbring, Jörg; Theobald, Matthias; Schetelig, Johannes und Kroeger, Nicolaus
(2018):
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.
In: Bone Marrow Transplantation, Bd. 53, Nr. 3: S. 255-263
Cramer, Paula; Tresckow, Julia von; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara und Hallek, Michael
(2018):
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial.
In: Lancet Oncology, Bd. 19, Nr. 9: S. 1215-1228
Bokemeyer, Carsten; Busse, Reinhard; Engel, Jutta; Gebauer, Alexander; Hallek, Michael; Heinemann, Volker; Lüftner, Diana und Wörmann, Bernhard
(2018):
Der ältere Krebspatient - Herausforderungen im Krankenhaus und in der Praxis.
In: Oncology Research and Treatment, Bd. 41, Nr. Suppl 3: S. 2-26
[PDF, 569kB]
Brocks, Tania; Fedorchenko, Oleg; Schliermann, Nicola; Stein, Astrid; Moll, Ute M.; Seegobin, Seth; Dewor, Manfred; Hallek, Michael; Marquardt, Yvonne; Fietkau, Katharina; Heise, Ruth; Huth, Sebastian; Pfister, Herbert; Bernhagen, Jürgen; Bucala, Richard; Baron, Jens M. und Fingerle-Rowson, Guenter
(2017):
Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.
In: FASEB Journal, Bd. 31, Nr. 2: S. 526-543
Fischer, Kirsten; Al-Sawaf, Othman; Fink, Anna-Maria; Dixon, Mark; Bahlo, Jasmin; Warburton, Simon; Kipps, Thomas J.; Weinkove, Robert; Robinson, Sue; Seiler, Till; Opat, Stephen; Owen, Carolyn; Lopez, Javier; Humphrey, Kathryn; Humerickhouse, Rod; Tausch, Eugen; Frenzel, Lukas; Eichhorst, Barbara; Wendtner, Clemens-M.; Stilgenbauer, Stephan; Langerak, Anton W.; Dongen, Jacque J. M. van; Böttcher, Sebastian; Ritgen, Matthias; Göde, Valentin; Mobasher, Mehrdad und Hallek, Michael
(2017):
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
In: Blood, Bd. 129, Nr. 19: S. 2702-2705
Wendtner, Clemens M.; Hallek, Michael; Fraser, Graeme A. M.; Michallet, Anne-Sophie; Hillmen, Peter; Dürig, Jan; Kalaycio, Matt; Gribben, John G.; Stilgenbauer, Stephan; Buhler, Andreas; Kipps, Thomas J.; Purse, Brendan; Zhang, Jennie; De Bedout, Sabine; Mei, Jay und Chanan-Khan, Asher
(2016):
Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*.
In: Leukemia & Lymphoma, Bd. 57, Nr. 6: S. 1291-1299
Maurer, Christian; Pflug, Natali; Bahlo, Jasmin; Kluth, Sandra; Rhein, Christina; Cramer, Paula; Gross-Ophoff, Carolin; Langerbeins, Petra; Fink, Anna-Maria; Eichhorst, Barbara; Kreuzer, Karl-Anton; Fischer, Norbert; Tausch, Eugen; Stilgenbauer, Stephan; Böttcher, Sebastian; Döhner, Hartmut; Kneba, Michael; Dreyling, Martin; Binder, Mascha; Hallek, Michael; Wendtner, Clemens-Martin; Bergmann, Manuela und Fischer, Kirsten
(2016):
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia.
In: European Journal of Haematology, Bd. 97, Nr. 3: S. 253-260
Savani, Bipin N.; Labopin, Myriam; Blaise, Didier; Niederwieser, Dietger; Ciceri, Fabio; Ganser, Arnold; Arnold, Renate; Afanasyev, Boris; Vigouroux, Stephane; Milpied, Noel; Hallek, Michael; Cornelissen, Jan J.; Schwerdtfeger, Rainer; Polge, Emmanuelle; Baron, Frédéric; Esteve, Jordi; Gorin, Norbert C.; Schmid, Christoph; Giebel, Sebastian; Mohty, Mohamad und Nagler, Arnon
(2016):
Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
In: Haematologica, Bd. 101, Nr. 2: S. 256-262
[PDF, 776kB]
Pohlen, Michele; Thoennissen, Nils H.; Braess, Jan; Thudium, Johannes; Schmid, Christoph; Kochanek, Matthias; Kreuzer, Karl-Anton; Lebiedz, Pia; Görlich, Dennis; Gerth, Hans U.; Rohde, Christian; Kessler, Torsten; Müller-Tidow, Carsten; Stelljes, Matthias; Büchner, Thomas; Schlimok, Günter; Hallek, Michael; Waltenberger, Johannes; Hiddemann, Wolfgang; Berdel, Wolfgang E.; Heilmeier, Bernhard und Krug, Utz
(2016):
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.
In: PLOS ONE 11(8), e0160871 [PDF, 1MB]
In: PLOS ONE 11(8), e0160871 [PDF, 1MB]
Konferenzbeitrag
Szinicz, Ladislaus; Hallek, Michael; Arbogast, Helmut; Arndt, Holger und Wentz, Maria
(1989):
Treatment of behavioral impairment caused by soman in mice.
3. International Symposium on Protection against Chemical Warfare Agents, Umea (Schweden), 11. - 16.06.1989.
In: International Symposium on Protection against Chemical Warfare Agents,
S. 173-178
[PDF, 626kB]